Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
about
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAmiodarone versus other pharmacological interventions for prevention of sudden cardiac deathAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAmiodarone versus other pharmacological interventions for prevention of sudden cardiac deathAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationABC of atrial fibrillation. Drugs for atrial fibrillationAtrial Fibrillation: The Science behind Its DefianceNon-pharmacological treatment of atrial fibrillationMinimally invasive surgery for atrial fibrillation: toward a totally endoscopic, beating heart approach.Azimilide dihydrochloride: a new class III anti-arrhythmic agent.Cytochrome P450-2D6 Genotype Definition May Improve Therapy for Paroxysmal Atrial Fibrillation A Case of Syncope Following "Pill-in-the-Pocket" Quinidine plus Propafenone.Atrial Fibrillation: The New Epidemic of the Ageing WorldThe diagnosis of syncope in the elderly.Data-driven Decisions: The Importance of Clinical Trials in Arrhythmia Management.Technology assessment in dentistry: a comparison of the longevity and cost-effectiveness of inlays.Wireless Smartphone ECG Enables Large-Scale Screening in Diverse Populations.Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.Predicting antiarrhythmic performance.What should we expect from the next generation of antiarrhythmic drugs?Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system.Catheter ablation in supraventricular tachyarrhythmias.Atrial fibrillation: prevalence and management in an acute general medical unit.Management of intermittent atrial fibrillation: drugs to maintain sinus rhythm.Optimal management of the patient with chronic atrial fibrillation: whom to cardiovert?The role of nonpharmacologic therapies for the treatment of atrial fibrillation.Antithrombotic therapy in nonrheumatic/nonvalvular atrial fibrillation.Optimal management with Class I and Class III antiarrhythmic drugs should be done in the outpatient setting: protagonist.Management of the older person with ventricular arrhythmias.Transvenous atrial defibrillation--techniques and clinical applications.Antiarrhythmic drugs for atrial fibrillation.Dofetilide: a class III-specific antiarrhythmic agent.Update on Atrial Fibrillation: Restoration of Sinus Rhythm or Ventricular Rate Control?Pharmacological management of atrial fibrillation: an update.Therapy of atrial fibrillation: rhythm control versus rate control.Drug-induced QT interval prolongation: mechanisms and clinical managementAntiarrhythmic drugs: from mechanisms to clinical practice.Atrial fibrillation: current and future strategies for management.Atrial fibrillation pearls and perils of managementNew insights into the mechanisms and management of atrial fibrillation
P2860
Q24187110-17D6D795-51AC-4A3A-806B-9AB0E20F7307Q24187185-E5F4509F-6199-4D9D-9C9B-320F8D848DCFQ24197643-02A2B6B1-A66E-46CC-BF57-5448128024B0Q24240892-E26FF63A-C3E0-446A-B5B6-8ECA7B36256EQ24243067-9D78D05D-6A4E-490B-94DB-006201753155Q24246498-E19457D8-C752-48B8-A365-BAED065EE001Q24645167-868BBCCB-F414-4FCD-931C-9C89ED672D4AQ28072139-A7A84671-A0B5-4E25-BDC0-D7DD118A4752Q28200564-E25B53DE-F66E-44CD-A33B-8057E0234170Q31063113-1EFF318E-E04C-47C7-951D-11AFAFD5ADEAQ31522245-2E4F2905-FBBC-4DEB-B8B2-CA84D2890E4BQ33168000-01F4220A-F8FF-4031-BD0F-D408DE8DB13FQ33168630-0C4DC79C-E69B-4CB1-AB44-4607055BE0CAQ33174457-59C04342-8866-430E-A584-B1055DBBE5A8Q33179799-2EAB71C6-A7EC-496E-94C2-400B6EA25D54Q33221988-C2DA8D78-7B3D-4A71-B64C-8DAC016A4EA0Q33442762-DDEEB67A-56DE-44A0-ADC2-6D1C4A84196AQ33544548-B9DC0718-6C2B-43D2-A3E1-34DE5CE09C6DQ33544551-292CF22F-7AB8-4E2C-A237-FE3719185C99Q33544553-D1EA997C-9302-4EB5-A082-DD3CCDF2394EQ33565950-1D1E917D-C3AF-408B-9EB0-BA93B76775EDQ33568670-AE5075B1-6C1B-4FF6-9A2F-440DB70AA4E2Q33592414-5E57F3F5-152F-4F87-8AC6-B7AE83231AF1Q33597990-1C513D40-ACA8-423C-86DB-8BF9B852C023Q33597995-F35385EF-D274-4D5D-B687-4F81EF61AF23Q33598003-E081A844-D0E2-442D-99F6-68ECE3FA83A5Q33598010-AF28F068-4C2B-4171-85E3-0303CC5031D1Q33598017-5904C23E-802D-4923-9D53-408D2C24F363Q33686613-35CF1426-4D5D-4C51-BDA8-4CBF2A92CE75Q33754156-CA97AB56-FFF3-4B58-837F-7F87383F2684Q33821199-C7168F9E-479A-4AA9-8689-8B44A3638956Q33834871-56452968-4D6E-4305-A059-8421A9B1B812Q33843408-A4258FBF-586F-409A-8747-74B6D4CC0DDCQ33845159-97E6389E-4F1D-46E1-9BD9-7A8264EFCA65Q33931009-CDFFF315-DC1D-4390-9AA7-B829F593296EQ33949538-BB4598D7-3FD1-40A6-A183-C37D623D9FA4Q34012641-6AA948B9-5247-4F35-B868-EE9862191DE1Q34126043-6395F14B-A154-45A7-AC45-EE87AD2D5F51Q34183370-22A820AC-11E6-4BB9-A975-9F82E4AEC555Q34289414-13E4FECC-9B59-4DF2-BB4F-109B306C4AE5
P2860
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Efficacy and safety of quinidi ...... of randomized control trials.
@en
Efficacy and safety of quinidi ...... of randomized control trials.
@nl
type
label
Efficacy and safety of quinidi ...... of randomized control trials.
@en
Efficacy and safety of quinidi ...... of randomized control trials.
@nl
prefLabel
Efficacy and safety of quinidi ...... of randomized control trials.
@en
Efficacy and safety of quinidi ...... of randomized control trials.
@nl
P2093
P356
P1433
P1476
Efficacy and safety of quinidi ...... of randomized control trials.
@en
P2093
P304
P356
10.1161/01.CIR.82.4.1106
P407
P577
1990-10-01T00:00:00Z